ASCL1 and breast cancer: Ascl1 (ASH1L), the activity of which increased in AD and declined in BC compared to control samples in the NCA results, is central to the differentiation of neuroblasts and the lateral inhibition mechanism, which inherently creates a safety net in the event of damage or death in these incredibly important cells, as well as neuronal commitment [45].